Mayo Clinic-led research team identifies master switch for cancer-causing HER2 protei

[News]

Herceptin has been touted as a wonder drug for women with HER2-positive breast cancer, an aggressive form of the disease that is fueled by excess production of the HER2 protein.

More... (http://www.medicalnewstoday.com/releases/293167.php)